Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acipimox (K-9321) is a niacin derivative and nicotinic acid analog with activity as a hypolipidemic agent. Acipimox has special application for the treatment of hyperlipidemia in non-insulin-dependent diabetic patients.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 7,000 | |||
25 mg | 在庫あり | ¥ 11,000 | |||
50 mg | 在庫あり | ¥ 15,000 | |||
100 mg | 在庫あり | ¥ 22,500 | |||
200 mg | 在庫あり | ¥ 33,000 | |||
500 mg | 在庫あり | ¥ 55,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 9,000 |
説明 | Acipimox (K-9321) is a niacin derivative and nicotinic acid analog with activity as a hypolipidemic agent. Acipimox has special application for the treatment of hyperlipidemia in non-insulin-dependent diabetic patients. |
別名 | Olbemox, K-9321 |
分子量 | 154.12 |
分子式 | C6H6N2O3 |
CAS No. | 51037-30-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15.4 mg/mL (100 mM)
H2O: 15.4 mg/mL (100 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Acipimox 51037-30-0 Others nicotinic acid Olbemox K 9321 K9321 K-9321 derivative antilipolytic lipolysis analogue inhibit autonomic tone Inhibitor diabetes inhibitor